Home / Nervous system / Apomorphine
ATC N04BC07 · Dopamine Agonists
Apomorphine shortage
As of 2 Nov 2026, Apomorphine has a reported shortage in 2 of the 15 countries we track (Canada, Sweden), covering 3 products from 1 company.
Countries2/15
Products3packs or presentations
Companies10 listed
Short since1 Oct 20233.1 years ago
Earliest return31 Dec 2026company estimate
Main reasonNot stated
United StatesNo reported shortageCanada2 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSweden1 product shortJapanNo reported shortageAustraliaNo reported shortage
Timeline
CanadaSweden
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group N04BC · Dopamine AgonistsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MOVAPO (30MG/3ML PRE-FILLED PEN) | PALADIN LABS INC. | 1 Oct 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MOVAPO (5x 3mL) discontinuation | PALADIN LABS INC. | not given | not given | Not stated |
| SE | APO-go PEN 10 mg/ml Förfylld injektionspenna, 5 x 3 ml | 2 Jan 2026 | 31 Dec 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.